5-76132055-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_014979.4(SV2C):c.305C>T(p.Ala102Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000209 in 1,611,036 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_014979.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SV2C | NM_014979.4 | c.305C>T | p.Ala102Val | missense_variant | 2/13 | ENST00000502798.7 | NP_055794.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SV2C | ENST00000502798.7 | c.305C>T | p.Ala102Val | missense_variant | 2/13 | 1 | NM_014979.4 | ENSP00000423541 | P1 | |
SV2C | ENST00000322285.7 | c.305C>T | p.Ala102Val | missense_variant | 2/13 | 2 | ENSP00000316983 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 151962Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000102 AC: 25AN: 246212Hom.: 0 AF XY: 0.0000974 AC XY: 13AN XY: 133470
GnomAD4 exome AF: 0.000220 AC: 321AN: 1458956Hom.: 0 Cov.: 30 AF XY: 0.000223 AC XY: 162AN XY: 725494
GnomAD4 genome AF: 0.000105 AC: 16AN: 152080Hom.: 0 Cov.: 31 AF XY: 0.0000807 AC XY: 6AN XY: 74316
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 12, 2021 | The c.305C>T (p.A102V) alteration is located in exon 2 (coding exon 1) of the SV2C gene. This alteration results from a C to T substitution at nucleotide position 305, causing the alanine (A) at amino acid position 102 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at